|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 24, 2023
|
Q2 FY2023
As of Jun 25, 2023
|
Q1 FY2023
As of Mar 26, 2023
|
Q4 FY2022
As of Dec 25, 2022
|
Q3 FY2022
As of Sep 25, 2022
|
Q2 FY2022
As of Jun 26, 2022
|
Q1 FY2022
As of Mar 27, 2022
|
Q4 FY2021
As of Dec 26, 2021
|
Q3 FY2021
As of Sep 26, 2021
|
Q2 FY2021
As of Jun 27, 2021
|
Q1 FY2021
As of Mar 28, 2021
|
Q4 FY2020
As of Dec 27, 2020
|
Q3 FY2020
As of Sep 27, 2020
|
Q2 FY2020
As of Jun 28, 2020
|
Q1 FY2020
As of Mar 29, 2020
|
Q4 FY2019
As of Dec 29, 2019
|
Q3 FY2019
As of Sep 29, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Lease incentives receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets and intangible assets, net | ||||||||||||||||||||
| Tradename | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Accrued deferred rent | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Contingencies | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.01 par value; 60,000,000 shares authorized; 17,230,284 shares issued and outstanding at June 30, 2024 and 17,335,062 shares issued and outstanding at December 31, 2023 | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 15,000,000 shares authorized and no shares issued or outstanding at June 30, 2024 and December 31, 2023 | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
